Ipilimumab vs Mometasone Furoate
Ipilimumab vs Mometasone Furoate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Mometasone Furoate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Mometasone Furoate β Small molecule.